Main content

The Synthesis of Novel Lewis B and Oncofetal ‘H’ Oligosaccharides for Immunological Studies

Show full item record

Title: The Synthesis of Novel Lewis B and Oncofetal ‘H’ Oligosaccharides for Immunological Studies
Author: Pickles, Matisse
Department: Department of Chemistry
Program: Chemistry
Advisor: Auzanneau, France Isabelle
Abstract: Synthesis of two Lewis B analogues (L-Fuc-α-(1→2)-D-Gal-β-(1→3)[L-Fuc-α-1→4]GlcNAc-β-(1→O)(CH2)6R), where R is representative of an amine or a hydrogen, is described. We initially explored various reaction conditions and donor leaving groups for the creation of the gal-β-(1→3)-GlcNAc glycoside. A D-Gal O-6 benzyl protecting group was vital to the synthesis, however we experienced difficulties retaining this group when creating our bromide donor using known acidic conditions. Thus, we explored novel conditions for the formation of 2,3,4-tri-o-acetyl-6-o-benzyl-1-bromo-α-D-galactoside and found more efficient methods than using HBr. Following synthesis of the Gal-β-(1→3)-GlcNAc glycoside, the desired analogue was generated via difucosylation in 63% yield. The difucosylation also gave a trisaccharide in 20% yield. The trisaccharide was thought to be L-Fuc-α-(1→2)-D-Gal-β-(1→3)[L-Fuc-α-1→4] GlcNAc-β-(1→O)(CH2)6Cl, an analogue of another carbohydrate antigen. NMR analysis, namely ROESY experiments, helped fully elucidate the L-Fuc-α-(1→2)-D-Gal-β-(1→3)[L-Fuc-α-1→4]GlcNAc-β-(1→O)(CH2)6R structure. Aglycone functionalizations and deprotections generated two analogues of Lewis B and two analogues of the ’H’ antigen, respectively.
Date: 2021
Terms of Use: All items in the Atrium are protected by copyright with all rights reserved unless otherwise indicated.

Files in this item

Files Size Format View Description
Pickles_Matisse_202109_MSc.pdf 3.619Mb PDF View/Open Thesis

This item appears in the following Collection(s)

Show full item record